- Home
- LODE vs IOBT Comparison
LODE vs IOBT Comparison
Compare LODE & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- IOBT
- Stock Information
- Founded
- LODE 2008
- IOBT 2014
- Country
- LODE United States
- IOBT Denmark
- Employees
- LODE N/A
- IOBT N/A
- Industry
- LODE Major Chemicals
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- LODE Industrials
- IOBT Health Care
- Exchange
- LODE Nasdaq
- IOBT Nasdaq
- Market Cap
- LODE 119.2M
- IOBT 114.6M
- IPO Year
- LODE N/A
- IOBT 2021
- Fundamental
- Price
- LODE $2.93
- IOBT $1.76
- Analyst Decision
- LODE Hold
- IOBT Strong Buy
- Analyst Count
- LODE 1
- IOBT 2
- Target Price
- LODE $4.00
- IOBT $8.00
- AVG Volume (30 Days)
- LODE 1.0M
- IOBT 1.9M
- Earning Date
- LODE 10-21-2025
- IOBT 11-11-2025
- Dividend Yield
- LODE N/A
- IOBT N/A
- EPS Growth
- LODE N/A
- IOBT N/A
- EPS
- LODE N/A
- IOBT N/A
- Revenue
- LODE $3,280,749.00
- IOBT N/A
- Revenue This Year
- LODE $16.44
- IOBT N/A
- Revenue Next Year
- LODE $800.34
- IOBT N/A
- P/E Ratio
- LODE N/A
- IOBT N/A
- Revenue Growth
- LODE 58.55
- IOBT N/A
- 52 Week Low
- LODE $1.67
- IOBT $0.66
- 52 Week High
- LODE $10.10
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- LODE 58.38
- IOBT 48.52
- Support Level
- LODE $2.82
- IOBT $1.71
- Resistance Level
- LODE $3.08
- IOBT $2.08
- Average True Range (ATR)
- LODE 0.15
- IOBT 0.15
- MACD
- LODE 0.09
- IOBT 0.01
- Stochastic Oscillator
- LODE 76.54
- IOBT 40.91
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.